We are Napo Therapeutics: an European pharmaceutical company, a young start-up led by a team of experienced professionals.

Our mission is to improve the quality of life of people suffering from rare diseases and pathologies with a strong unmet medical need through innovative solutions.

Our name reflects our story: The Napo River crosses the territories of the Amazon where the Croton lechleri ​​tree grows – the plant from which we extract the sap that contains a precious active ingredient. We are studying an innovative and first-in-class drug thanks to the novel mechanism of action of this active ingredient, in order to register it throughout Europe. Right now, our focus is on two serious rare diseases: short bowel syndrome (SBS) and congenital diarrheal disorders (CDD).

Our majority shareholder is Napo Pharmaceuticals, a wholly owned subsidiary of Jaguar Health, which is headquartered in San Francisco, California and listed on NASDAQ (JAGX); in Milan, we represent the European headquarters of Napo Therapeutics.

The Napo Way

The Napo Way is the model that defines our essence.

Business strategies and choices are based on a circular action model: we draw the tools for human healthcare from nature and we try to give back to nature, committing ourselves to preserving the ecosystem in concert with principles of environmental and social sustainability.

  • RESPONSIBILITY towards the patient: our research is not only inspired but also guided by patients, by listening to and dialoguing with them; our results are achieved thanks to the active participation of each of them.
  • Respect for the patient’s DIGNITY: we put our personal and professional experience at the service of patients not only to offer them the best clinical treatments but also to help people build the life they want.
  • SUSTAINABILITY: our model is based on the sustainable regeneration of the ecosystems in which we operate. We strive to act in harmony with the environment, society and the market to generate virtuous changes.